Structure Therapeutics is trading at $49.94 (+5.47%) in pre-market as the stock gains alongside a broader market rally despite no clear company-specific catalyst identified in current news flow.
- Broader markets are firmer, with the S&P 500 up 0.65% and the Nasdaq Composite gaining 1.41%.
- The positive risk-on environment appears to be supporting speculative sentiment within the biotechnology sector.